Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
Oncogene
|
April 18, 1998
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin
R Pinkas-Kramarski, A E Lenferink, S S Bacus, et al.
Nature
|
September 18, 1986
Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors
Y Yarden, J A Escobedo, W J Kuang, et al.
The EMBO Journal
|
June 17, 1998
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers
A E Lenferink, R Pinkas-Kramarski, M L van de Poll, et al.
The Journal of Biological Chemistry
|
May 30, 1998
Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes
M Shelly, R Pinkas-Kramarski, B C Guarino, et al.
The EMBO Journal
|
August 15, 1997
Bivalence of EGF-like ligands drives the ErbB signaling network
E Tzahar, R Pinkas-Kramarski, J D Moyer, et al.
Molecular and Cellular Biology
|
December 28, 1999
Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway
R J Lee, C Albanese, M Fu, et al.
Oncogene
|
May 9, 2007
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling
K Shtiegman, B S Kochupurakkal, Y Zwang, et al.
Oncogene
|
June 20, 1996
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
S S Bacus, Y Yarden, M Oren, et al.
Oncogene
|
July 12, 2011
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling
C-R Pradeep, W J Köstler, M Lauriola, et al.
Oncogene
|
December 6, 2011
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
C-R Pradeep, A Zeisel, W J Köstler, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
Oncogene
|
April 18, 1998
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin
R Pinkas-Kramarski, A E Lenferink, S S Bacus, et al.
Nature
|
September 18, 1986
Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors
Y Yarden, J A Escobedo, W J Kuang, et al.
The EMBO Journal
|
June 17, 1998
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers
A E Lenferink, R Pinkas-Kramarski, M L van de Poll, et al.
The Journal of Biological Chemistry
|
May 30, 1998
Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes
M Shelly, R Pinkas-Kramarski, B C Guarino, et al.
The EMBO Journal
|
August 15, 1997
Bivalence of EGF-like ligands drives the ErbB signaling network
E Tzahar, R Pinkas-Kramarski, J D Moyer, et al.
Molecular and Cellular Biology
|
December 28, 1999
Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway
R J Lee, C Albanese, M Fu, et al.
Oncogene
|
May 9, 2007
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling
K Shtiegman, B S Kochupurakkal, Y Zwang, et al.
Oncogene
|
June 20, 1996
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
S S Bacus, Y Yarden, M Oren, et al.
Oncogene
|
July 12, 2011
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling
C-R Pradeep, W J Köstler, M Lauriola, et al.
Oncogene
|
December 6, 2011
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
C-R Pradeep, A Zeisel, W J Köstler, et al.
Page
of 17